Ofatumumab: a second generation anti-CD20 monoclonal antibody in chronic lymphocytic leukemia. Hematol Meeting Rep [Internet]. 2009 Jun. 12 [cited 2025 Jun. 20];3(3). Available from: https://journals.pagepress.org/hmr/article/view/583